Soumitra Roy
36Patents
17h-index
21Co-inventors
81Inventor score
Filing activity: Jun 13, 1991 → May 19, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7247472B2 | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use | Chemistry; Metallurgy | 99 | Expired |
| US7291498B2 | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses | Chemistry; Metallurgy | 68 | Expired |
| US5922315A | Adenoviruses having altered hexon proteins | Chemistry; Metallurgy | 67 | Expired |
| US7491508B2 | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses | Chemistry; Metallurgy | 61 | Expired |
| US8470310B2 | Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof | Chemistry; Metallurgy | 54 | Active |
| US8231880B2 | Simian subfamily C adenoviruses SAdV-40, -31, and -34 and uses thereof | Chemistry; Metallurgy | 52 | Active |
| US8524219B2 | Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof | Emerging Cross-Sectional Technologies | 49 | Active |
| US8105574B2 | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use | Chemistry; Metallurgy | 48 | Active |
| US9217159B2 | Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof | Chemistry; Metallurgy | 48 | Active |
| US8834863B2 | Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof | Chemistry; Metallurgy | 46 | Active |
| US8603459B2 | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use | Chemistry; Metallurgy | 44 | Active |
| US9593346B2 | Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof | Chemistry; Metallurgy | 43 | Active |
| US9597363B2 | Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof | Chemistry; Metallurgy | 43 | Active |
| US9617561B2 | Simian adenovirus 41 and uses thereof | Chemistry; Metallurgy | 37 | Active |
| US5346991A | Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders | Emerging Cross-Sectional Technologies | 30 | Expired |
| US8940290B2 | Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof | Chemistry; Metallurgy | 24 | Active |
| US5589363A | DNA encoding tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5739101A | Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders | Emerging Cross-Sectional Technologies | 14 | Expired |
| US8685387B2 | Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 | Chemistry; Metallurgy | 12 | Active |
| US11020476B2 | Methods and compositions for inducing an immune response against Hepatitis B Virus (HBV) | Chemistry; Metallurgy | 11 | Active |
| US8846031B2 | Simian adenovirus 41 and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US10113182B2 | Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US10149873B2 | Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US9359618B2 | Simian subfamily E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38 and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US9382551B2 | Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof | Chemistry; Metallurgy | 9 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.